Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05869318 · ClinicalTrials.gov registry record · NA

Respiratory Effects of E-Cigarettes in Obese Youth

A NA study of E-Cig Use, sponsored by Ohio State University Comprehensive Cancer Center.

Active
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT05869318: Active NA study of E-Cig Use, sponsored by Ohio State University Comprehensive Cancer Center.

NCT05869318 is a NA study of E-Cig Use that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 56 participants, below the 145-participant average among 9 other E-Cig Use trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05869318, a NA study of E-Cig Use, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

To determine vaping behaviors and respiratory function in obese and nonobese youth e-cigarette users.

Primary Outcome

Spirometry will be completed before and after a 35 min vaping session

Conditions Studied

Interventions

  • OTHER ECIG own
  • OTHER ECIG Vuse

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2023-04-04
Est. Completion 2027-12-31
Phase NA

What the registry record for NCT05869318 still lists

NCT05869318 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 145-participant average among 9 other E-Cig Use trials with a reported enrollment target (61% lower).

The record links to 1 condition, with E-Cig Use appearing as the primary indexed condition, and to 2 interventions - of which ECIG own is the first listed.

NCT05869318 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT05869318 about?

NCT05869318 is a clinical study titled "Respiratory Effects of E-Cigarettes in Obese Youth". To determine vaping behaviors and respiratory function in obese and nonobese youth e-cigarette users.

What is the current status of trial NCT05869318?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2023-04-04. Estimated completion is 2027-12-31.

What conditions does trial NCT05869318 study?

This clinical trial studies the following conditions: E-Cig Use.

What interventions are being tested in trial NCT05869318?

The interventions under investigation include: ECIG own (OTHER), ECIG Vuse (OTHER).

Who is sponsoring clinical trial NCT05869318?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05869318 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for E-Cig Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05869318's enrollment target sits among peer trials

56 7th of 9 higher than 3 of 9 other E-Cig Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other E-Cig Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05869318, the US trial registry maintained by the National Library of Medicine. NCT05869318 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.